Hualan Group: Wholly owned subsidiary plans to invest 50 million yuan to establish a wholly owned subsidiary.

Hua Lan announced that its wholly-owned subsidiary, Hainan Lingqing Artificial Intelligence Pharmaceutical Technology Co., Ltd., plans to use its own funds of RMB 50 million to invest in the establishment of a wholly-owned subsidiary, with RMB 10 million included in the registered capital and RMB 40 million included in capital reserves. The newly established subsidiary will focus on the research and application of AI-driven small molecule drug discovery technology, based on core algorithms such as 64-dimensional high-fidelity latent space and latent space flow matching, to build an innovative drug research and development platform that deeply integrates artificial intelligence and physical constraints.